Cannabis-Based Drug Receives First European Market Approvals for Chronic Back Pain
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
24 results for “europe”
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business of Cannabis Awards.
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, […]
The international patient-led organisation We, The Patients, will bring its educational series to London next month.
Findings from The European Cannabis Report: 10th Edition reflect a decade of immense change across European cannabis markets.
The concept of the medical cannabis card originated out of the US in some jurisdictions where patients are issued an annual card from their doctor which permits them to purchase medical cannabis from any legal dispensary.
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market.
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe Medical cannabis demand across Europe has seen substantial growth, particularly […]
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
Cannabis and psychedelic medicine were firmly on the agenda at the major European health innovation conference.
The Cognalyzer® scans EEG (brainwaves) of consumers and leverages AI to quantify if a person is experiencing psychoactive effects.
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater than expected due to ‘unusually high’ consumption volumes on a […]
Following the landmark legislative change in Germany earlier this month, experts are expecting to see a ripple effect across the continent.
We asked experts in the European cannabis sector about their predictions for 2024.
Global sales of adult-use cannabis are projected to double worldwide by 2027.
Six years after the legalisation of medical cannabis in Greece, the majority of patients are still relying on the illegal market.
A sixth pilot for the sale of adult-use cannabis has been approved in Basel-Landschaft.
The monograph will be used to provide new specifications and standards for cannabis-based medicines in Europe.
A new report from a UK cannabis advisory company has highlighted how a failure to capture data related to race – when policing illicit adult cannabis use across Europe – […]
Your weekly debrief of the latest cannabis news.
The European Parliament held its first ever debate on the legalisation of cannabis last week.
Your weekly debrief of the latest cannabis news.
The annual European Drug Report gives an overview of the key trends in drug use across the EU.
The ‘legal high’ Hexahydrocannabinol, better known as HHC, is on the rise across Europe. Here’s what you need to know.